Frontmasta
11.01.2018 kl 20:45
539

FRA Springer

22 Nov 2017
Nordic Nanovector plans the pivotal phase II PARADIGME trial for Follicular lymphoma (Second-line therapy or greater) in the second half of 2017 (Trial profile 700237368)

22 Nov 2017
Nordic Nanovector plans the phase II ARCHER-1 trial for Follicular lymphoma (Second-line therapy, Combination therapy) in the second half of 2017 (Trial profile 700285282)

DET HJELPER Å SØKE-LESE PÅ INTERNETT.
Arkivert